Results 91 to 100 of about 28,704 (262)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2009
Miguel A Teus1, Stefano Miglior2, Guna Laganovska3, Lasma Volksone4, Bozena Romanowska-Dixon5, Roman Gos6, Gábor Holló7, for the C-05-25 Study Group81Hospital Príncipe de Astúrias, Universidad de Alcal& ...
Miguel A Teus, Stefano Miglior, Guna Laganovska, et al   +3 more
doaj  

Direct Inhibition of N-Methyl-D-Aspartate (NMDA)-Receptor Function by Antiglaucomatous β-Antagonists

Journal of Pharmacological Sciences, 2008
In the present study, we investigated the direct effects of antiglaucoma drugs (timolol, betaxolol, pilocarpine, and latanoprost) on N-methyl-D-aspartate (NMDA)-receptor function using a Xenopus oocytes expression system and electrophysiological ...
Tatsuo Nagata, Susumu Ueno, Hirofumi Morita, Toshiaki Kubota, Yumiko Toyohira, Masato Tsutsui, Akihiko Tawara, Nobuyuki Yanagihara   +7 more
doaj   +1 more source

Bimatoprost/timolol fixed combination versus latanoprost in treatment-naïve glaucoma patients at high risk of progression: a pilot study. [PDF]

, 2017
Objective To compare a fixed combination of 0.03% bimatoprost and 0.5% timolol (BTFC) with latanoprost monotherapy (LM) in treatment-naïve patients with open-angle glaucoma (OAG) and risk factors for glaucomatous progression.
GIFT study group, Gutierrez Díaz, Esperanza, Gutierrez Ortiz, Consuelo, Maltman, John, Millá, Elena, Morgan Warren, Robert J., Muñoz Negrete, Francisco J., Silva Cotta, Jose   +7 more
core   +1 more source

Clinical‐Pharmacological Drug Information Center of Hannover Medical School: Update From a Tertiary Care University Hospital (2022–2024)

Pharmacology Research &Perspectives, Volume 14, Issue 2, April 2026.
ABSTRACT Drug information centers (DICs) are institutions dedicated to providing independent and up‐to‐date information on medications and their usage to healthcare professionals. Here, we provide an update from the clinical‐pharmacological DIC of Hannover Medical School, covering the period from April 2022 to December 2024.
Johannes Heck, Dirk O. Stichtenoth, Christoph Schröder, Ruxandra Sabau, Anna‐Leena K. Heim, Felix Koop, Thorben Pape, Sebastian Schröder, Martin Schulze Westhoff, Benjamin Krichevsky, Martin Klietz, Stephan Greten, Carsten Schumacher   +12 more
wiley   +1 more source

Changes in visual function after intraocular pressure reduction using antiglaucoma medications [PDF]

, 2009
Purpose To evaluate the change in visual function after starting glaucoma treatment and correlate this to a decrease in intraocular pressure (IOP) in primary open-angle glaucoma patients.Methods A prospective, randomized clinical trial was carried out ...
A Harris, A Heijl, AS Hawkins, C Holmin, CS Tsai, D Regan, DW Evans, DW Evans, GN Pomerance, HA Quigley, J Flammer, JE Ross, JS Pointer, L A S Melo, LJ Katz, M V Piassi, O Arend, RN Weinreb, S Salim, SA Gandolfi, SA Gandolfi, T S Prata, WC Stewart   +22 more
core   +2 more sources

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME (US) study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 4, Page 846-858, April 2026.
Abstract Objectives/Background This study was undertaken to evaluate patient reasons for nonadoption of migraine‐preventive medications. Despite clear recommendations and eligibility criteria for migraine‐preventive treatment by the American Headache Society and the availability of these treatments, many people with migraine are not taking appropriate ...
Jessica Ailani, Rose Okonkwo, Elizabeth Johnston, Helen Hochstetler, Betzaida Martinez, Anthony Zagar, Robert A. Nicholson, Bert B. Vargas, E. Jolanda Muenzel, Richard B. Lipton   +9 more
wiley   +1 more source

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma

Türk Oftalmoloji Dergisi, 2012
Pur po se: To evaluate the effects of latanoprost/timolol maleate and dorzolamid/timolol maleate fixed combinations on-24 hours intraocular pressure in patients with open-angle glaucoma.
Berna Yüce, Suzan Güven Yılmaz, Kutay Andaç, Halil Ateş   +3 more
doaj   +1 more source

A study on the treatment of infantile hemangiomas with topical timolol

Indian Journal of Paediatric Dermatology, 2020
Introduction: With the advent of topical timolol, there has been a tremendous change in the management of infantile hemangiomas. Aims: The aim of the study was to evaluate the treatment response with topical 0.5% timolol drops in 20 children of infantile
Neerja Puri
doaj   +1 more source

Upper limits of intraocular pressure in glaucoma clinical trials [PDF]

, 2015
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/110560/1/ceo12357 ...
DeMill, David L, Nelson, Lindsay A, Stewart, William C, Wirostko, Barbara M   +3 more
core   +1 more source

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma

Frontiers in Oncology, 2017
The therapeutic options for infantile hemangiomas (IHs) have been greatly altered since the introduction of oral propranolol for successful treatments of IHs.
H. Wu, Chao Liu, Xuan Wang, Ling Zhang, Wei-En Yuan, Jia-wei Zheng, L. Su, X. Fan   +7 more
semanticscholar   +1 more source